Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 4.23 billion. The enterprise value is 10.19 billion.
Market Cap | 4.23B |
Enterprise Value | 10.19B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | Mar 18, 2025 |
Share Statistics
Dexco has 808.36 million shares outstanding. The number of shares has increased by 0.05% in one year.
Current Share Class | n/a |
Shares Outstanding | 808.36M |
Shares Change (YoY) | +0.05% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 20.71% |
Owned by Institutions (%) | 18.95% |
Float | 306.18M |
Valuation Ratios
The trailing PE ratio is 24.60 and the forward PE ratio is 11.64. Dexco's PEG ratio is 0.21.
PE Ratio | 24.60 |
Forward PE | 11.64 |
PS Ratio | 0.51 |
PB Ratio | 0.59 |
P/TBV Ratio | 0.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | 3.29 |
PEG Ratio | 0.21 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.35, with an EV/FCF ratio of -227.00.
EV / Earnings | 59.08 |
EV / Sales | 1.24 |
EV / EBITDA | 6.35 |
EV / EBIT | 25.12 |
EV / FCF | -227.00 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 1.07.
Current Ratio | 1.39 |
Quick Ratio | 0.93 |
Debt / Equity | 1.07 |
Debt / EBITDA | 4.59 |
Debt / FCF | -171.78 |
Interest Coverage | 0.62 |
Financial Efficiency
Return on equity (ROE) is 2.54% and return on invested capital (ROIC) is 2.03%.
Return on Equity (ROE) | 2.54% |
Return on Assets (ROA) | 1.66% |
Return on Invested Capital (ROIC) | 2.03% |
Return on Capital Employed (ROCE) | 3.30% |
Revenue Per Employee | 578,763 |
Profits Per Employee | 12,118 |
Employee Count | 14,228 |
Asset Turnover | 0.46 |
Inventory Turnover | 3.88 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.06% in the last 52 weeks. The beta is 0.56, so Dexco's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | -24.06% |
50-Day Moving Average | 5.65 |
200-Day Moving Average | 6.87 |
Relative Strength Index (RSI) | 51.91 |
Average Volume (20 Days) | 3,388,925 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 8.23 billion and earned 172.41 million in profits. Earnings per share was 0.21.
Revenue | 8.23B |
Gross Profit | 2.05B |
Operating Income | 478.35M |
Pretax Income | 344.47M |
Net Income | 172.41M |
EBITDA | 1.60B |
EBIT | 478.35M |
Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 1.81 billion in cash and 7.71 billion in debt, giving a net cash position of -5.74 billion or -7.10 per share.
Cash & Cash Equivalents | 1.81B |
Total Debt | 7.71B |
Net Cash | -5.74B |
Net Cash Per Share | -7.10 |
Equity (Book Value) | 7.20B |
Book Value Per Share | 8.63 |
Working Capital | 1.42B |
Cash Flow
In the last 12 months, operating cash flow was 1.28 billion and capital expenditures -1.33 billion, giving a free cash flow of -44.88 million.
Operating Cash Flow | 1.28B |
Capital Expenditures | -1.33B |
Free Cash Flow | -44.88M |
FCF Per Share | -0.06 |
Margins
Gross margin is 24.90%, with operating and profit margins of 5.81% and 2.09%.
Gross Margin | 24.90% |
Operating Margin | 5.81% |
Pretax Margin | 4.18% |
Profit Margin | 2.09% |
EBITDA Margin | 19.45% |
EBIT Margin | 5.81% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.12%.
Dividend Per Share | 0.22 |
Dividend Yield | 4.12% |
Dividend Growth (YoY) | -81.61% |
Years of Dividend Growth | n/a |
Payout Ratio | 135.64% |
Buyback Yield | -0.05% |
Shareholder Yield | 4.06% |
Earnings Yield | 4.08% |
FCF Yield | -1.06% |
Stock Splits
The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.
Last Split Date | Dec 21, 2022 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Dexco has an Altman Z-Score of 1.15. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.15 |
Piotroski F-Score | n/a |